Sort
23,748 grants matching “melanoma”
MECHANISMS OF IMMUNOSUPPRESSION BY ONE DOSE OF ETHANOL
$186,643Louisiana State Univ Hsc Shreveport · R01 · FY2003 · AA
TOMOGRAPHIC/SPECTRAL IMAGING OF FGF-MED ANGIOGENESIS
$186,627University Of Pittsburgh At Pittsburgh · R01 · FY2000 · CA
Identification of small molecule inhibitors of USP15
$186,552Anton Simeonov · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR
GENETIC INSTABILITY AND THE CELL CYCLE
$186,544University Of Washington · P01 · FY2000 · CA
Programmable 'all-in-one' RNA as a molecular scaffold for targeted combinatorial innate immune activation
$186,537Connie Wu · University Of Michigan At Ann Arbor · R21 · FY2025 · EB
Melanoma suppressing functions of carcinoma oncogene FOXQ1
$186,506Mikhail Nikiforov · Roswell Park Cancer Institute Corp · R21 · FY2016 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP
$186,449University Of Pretoria · U10 · FY2000 · CA
Effects of a Novel Phospho-STAT2 inhibitor for Treatment of Stage IV Melanoma
$186,434Amy Beth Heimberger · University Of Tx Md Anderson Can Ctr · P50 · FY2011 · CA
The Impact of Innate Neuronal Immunity on Neurotropic Arbovirus Pathogenesis
$186,390David J Miller · University Of Michigan At Ann Arbor · R21 · FY2008 · AI
CELLULAR PROTEIN MATURATION AND DEGRADATION
$186,350University Of Massachusetts Amherst · R01 · FY2000 · CA
SBIR TOPIC 229 MELANOMA PHARMACODYNAMIC ASSAY FOR TARGETED THERAPY
$186,321Siconolfi Lisa · · N01 · FY2007 · CA
Core 3: Rexinoid Screening and Animal Core
$186,229Mohammad Athar · University Of Alabama At Birmingham · P01 · FY2021 · CA
Detection of Melanoma by Mesoscopic Spectral Imaging
$186,146University Of Pittsburgh At Pittsburgh · R21 · FY2003 · CA
MODULATION OF NF-kB ACTIVATION BY A NOVEL MITOCHONDRIAL E3 UBIQUITIN LIGASE
$186,121Claudio A.p. Joazeiro · Scripps Research Institute, The · R01 · FY2012 · GM
MODULATION OF NF-kB ACTIVATION BY A NOVEL MITOCHONDRIAL E3 UBIQUITIN LIGASE
$186,121Claudio A.p. Joazeiro · Scripps Research Institute, The · R01 · FY2011 · GM
Ipilimumab plus a galectin-3 inhibitor for metastatic melanoma
$185,992Brendan D Curti · Providence Portland Medical Center · R21 · FY2016 · CA
Enhancing Melanoma TIL Efficacy with Multifactor mRNA-Mediated T Cell Reprogramming
$185,977Samuel G Katz · Yale University · R21 · FY2024 · CA
Redox Mechanism Process of Nos2 and COX2 in Stroma tumor interaction
$185,930David Wink · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
VPF/VEGF IN NORMAL AND NEOPLASTIC SKIN ANGIOGENESIS
$185,896Massachusetts General Hospital · R01 · FY2000 · CA
PG545 synergizes with PARP inhibitors in ovarian cancer to disrupt DNA repair through modulation of DEK-RAD51 axis
$185,831Viji Shridhar · Mayo Clinic Rochester · R21 · FY2022 · CA
Discovery of PD-1/PDL-1 inhibitors from marine microbial natural products
$185,808William Fenical · University Of California, San Diego · R01 · FY2023 · CA
Discovery of PD-1/PDL-1 inhibitors from marine microbial natural products
$185,807William Fenical · University Of California, San Diego · R01 · FY2022 · CA
Rationally improving T cell-mediated immunotherapy using Sleeping Beauty mutagenesis
$185,760Laura Marie Rogers · Mayo Clinic Rochester · K22 · FY2021 · CA
Rationally improving T cell-mediated immunotherapy using Sleeping Beauty mutagenesis
$185,760Laura Marie Rogers · Mayo Clinic Rochester · K22 · FY2020 · CA
Rationally improving T cell-mediated immunotherapy using Sleeping Beauty mutagenesis
$185,760Laura Marie Rogers · Mayo Clinic Rochester · K22 · FY2019 · CA